Delivery Order SPE2DB20D1109-SPE2DB22FP56T

Award Date 7/7/22
Potential Completion Date 7/8/22
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,412.60, is a Firm Fixed Price Delivery Order to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical supplies. The contract has an ultimate completion date of March 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,825.20 firm fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The award has an ultimate completion date of June 10, 2024 and is not associated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $16,689.04. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the government with VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The $1,093.30 firm fixed-price delivery order has a completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,472.01 Firm Fixed Price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award for $1,323.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a delivery order type and firm fixed price pricing, is for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,343.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty medication, with an ultimate completion date of June 11, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,426.63 Firm Fixed Price Delivery Order covers the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,874.14 for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FP56T
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,700.60 Firm Fixed Price Delivery Order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty medication. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable streamlined government procurement of essential pharmaceutical and medical products for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:09 AM